The RSV prophylaxis programme demonstrated effectiveness, with a low RSVH rate among high-risk preterm infants. Extreme prematurity and bronchopulmonary dysplasia are the most significant risk factors for RSVH. Despite being a single-centre retrospective study, this is the first evaluation of RSV immunoprophylaxis in Oman and supports the case for a nationwide programme targeting high-risk infants.
Mandhari et al. (Fri,) studied this question.